Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
